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Abstract
A variety of benign etiologies of biliary stricture may initially be mistaken 
for hilar cholangiocarcinoma. Consequently, many patients undergo surgery for 
a benign disease that could have been treated medically. Eosinophilic cholangitis 
(EC) is an uncommon, benign, self-limiting disease that should be considered when 
approaching a case of obstructive jaundice since it causes biliary stricture forma-
tion. Transmural eosinophilic infiltration of the biliary tree is characteristic of 
EC. It may initially be indistinguishable from hilar cholangiocarcinoma. We worked 
on a case of a patient who was referred to our hospital for jaundice and abdominal 
mass investigation with the provisional diagnosis of cholangiocarcinoma. During 
the workup, the index of suspicion for malignancy remained high as the typical 
laboratory and radiological findings for benign causes of biliary stricture were not 
present. Hence, the patient underwent left hepatectomy with caudate lobe resec-
tion and received a retrograde diagnosis of EC. The case demonstrates that EC 
could present in the elderly with cardinal signs of cancer and absence of the typical 
findings of EC which was not previously reported. Furthermore, this disorder has 
been reported to respond well to steroid therapy, hence, diagnostic criteria for EC 
would provide another treatment option for elderly and/or those who are not fit 
for surgery.
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1. Introduction
While approaching a patient with jaundice, it is important to understand the 
different types and approach towards jaundice in order to reach the correct diagnosis. 
Similarly, when approaching a biliary stricture, one must consider benign as well as 
malignant etiologies since they can be clinically identical. Eosinophilic cholangitis 
(EC) is a rare benign disorder of the biliary tract which can cause biliary obstruction.
This is the first book that has a specific chapter for a very rare disease, eosino-
philic cholangitis. In this chapter, we will briefly discuss the approach towards 
jaundice before jumping to the main topic of eosinophilic cholangitis. We hope that 
you will find the information provided informative.
2. Approach to jaundice
Jaundice (i.e., icterus) is the buildup of bilirubin; a waste product stemmed from 
the metabolism of aging/destruction of red blood cells (RBCs), causing a yellowish 
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discoloration in tissues that are filled with elastic collagen, such as skin, sclera, and 
mucus membranes, etc. [1].
Let us take some cases here to further understand how jaundice can present.
2.1 Case-1
A 14-year-old (y/o) African-American male presented to the emergency depart-
ment (ED) with severe abdominal pain, swelling of both hands and jaundice. 
Family history includes two uncles that suffer from “blood problems.” Blood tests 
showed normal alkaline phosphatase (ALP), aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), bilirubin was 3.2 mg/dL (2.8 indirect). On periph-
eral blood smear, sickling was found. Hemoglobin electrophoresis confirmed SS 
hemoglobin and patient was diagnosed with sickle cell anemia (SCA).
2.2 Case-2
A 42-year-old Caucasian male presented to the office with 2 months of jaundice 
and abdominal pain. The patient had a blood transfusion in 1988 at the age of 15. 
Type of jaundice Differential diagnosis
Pre-hepatic 
(hemolytic)
• Excess aged/destroyed RBCs (e.g., hemolysis, blood transfusion)
• Decreased hepatic uptake (e.g., portosystemic shunt, drugs)
• Decreased conjugation (e.g., Gilbert’s syndrome)
Hepatic 
(hepatocellular)
• Excretion defect (Dubin-Johnson syndrome, Rotor syndrome)
• Viral hepatitis
• Hepatic steatosis
• Alcoholic hepatitis
• Non-alcoholic steatohepatitis
• Autoimmune hepatitis
• Ischemic hepatitis
• Drug-induced hepatitis
• Hemochromatosis
• Wilson’s disease
Post-hepatic 
(obstructive)
• Biliary tract disease (primary sclerosing cholangitis, primary biliary cirrhosis, 
eosinophilic cholangitis, etc.)
• Biliary tract obstruction (gallstones, cholangiocarcinoma, pancreatic or liver 
cancer, pancreatic pseudocyst, etc.)
Table 1. 
Types of Jaundice [2, 3].
Lab findings AST + ALT ALP Conjugated 
bilirubin 
(CB)
Unconjugated 
bilirubin 
(UCB)
Total 
bilirubin
Conjugated 
bilirubin in 
urine
Pre-hepatic 
(hemolytic)
Normal Normal Normal Normal/ Normal/ Negative
Hepatic 
(hepatocellular)
     Positive
Post-hepatic 
(obstructive)
   Normal  Positive
Table 2. 
Lab findings depending on type of jaundice [4].
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Physical exam showed typical signs of cirrhosis. Labs showed an ALP of 200, ALT 
2810, AST 2670 U/L, normal gamma-glutamyl transferase (GGT), bilirubin of 
3.3 mg/dL (2 direct, 1.3 indirect), and normal iron and copper levels. Patient was 
positive for hepatitis C, attributed to his previous blood transfusion. Alpha feto-
protein (AFP) levels were elevated and patient was scheduled for a liver ultrasound 
(US) and biopsy to rule out hepatocellular carcinoma (HCC).
Clinical findings Urine color Stool color Large 
spleen
Pre-hepatic (hemolytic) Normal Brown Positive
Hepatic (hepatocellular) Dark (combination of CB + urobilinogen) Slightly 
pale
Positive
Post-hepatic (obstructive) Dark (CB) Pale Negative
Table 3. 
Clinical findings depending on type of jaundice [4].
Figure 1. 
Approach to Jaundice.
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2.3 Case-3
A 39-year-old Caucasian female with a body mass index (BMI) of 36 and a history 
of hamishoto’s thyroiditis, presented to the ED with worsening itching and jaundice. 
Patient’s thyroid function tests were within normal range. Cholesterol was 310 mg/dL, 
ALP 318, ALT 24, AST 21, and GGT 1120 U/L. Liver US showed no signs of bile duct 
dilation. Anti-mitochondrial antibody (AMA) titers were elevated. Patient was 
diagnosed with primary biliary cholangitis (PBC) and was started on ursodiol.
Now what do we take from these three different cases, all of whom presented or 
were seen to have jaundice? To understand the different presentations of jaundice, 
let us classify it.
The causes of jaundice can be classified in different ways such as pre-hepatic 
(hemolytic), hepatic (hepatocellular), and post-hepatic (obstructive) (see Table 1). 
Now, we can differentiate between them in many laboratory and clinical findings 
(see Tables 2 and 3) and know how to approach it (see Figure 1).
Understanding the classification, differentiating lab results and approach 
towards jaundice is important. Figure 1 can help you as a guide in term of what 
to do and what to expect. It is helpful to keep it in mind as we go through the 
chapter.
3. Approach to eosinophilic cholangitis
3.1 Introduction
Now that we have established the approach towards obstructive jaundice. We 
will dig deeper into eosinophilic cholangitis.
EC is an uncommon, benign, self-limiting cause of biliary structure character-
ized by transmural eosinophilic infiltration of the biliary tree which may result in 
obstructive jaundice. The severity and prognosis vary considerably and may affect 
part or the entire biliary tree mimicking malignancy [5].
3.2 Pathogenesis
The exact pathogenesis is poorly understood.
The cause of eosinophilic cholangitis is unknown. In some reports, hypereo-
sinophilic syndrome (HES) has been mentioned as possible cause. The diagnosis of 
hypereosinophilic syndrome is based on the following criteria [6]:
1. Sustained eosinophilia (more than 1500 eosinophils per cubic millimeter) for 
more than 6 months.
2. The absence of other causes of eosinophilia, including parasitic infections and 
allergies.
3. Signs and symptoms of organ involvement.
Since all reported cases do not appear to have completely met the criteria for 
HES, the relationship between eosinophilic cholangitis and HES is uncertain.
An allergic mechanism is thought to play a key role in the development of 
eosinophilic cholangitis, hence the name. In most reported cases, there was an 
increased level of IgE, interleukin 5, or eosinophilic cationic protein. The latter is 
one of the major cationic granules released by activated eosinophils and is the most 
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widely used clinical biomarker of eosinophil in atopic diseases. Furthermore, it 
has been it has been demonstrated that eosinophils produce transforming growth 
factor-beta, a cytokine known to stimulate fibrosis, a devastating effect that may 
leave liver transplantation as the only cure [7, 8].
3.3 Clinical presentation
Nash et al. conducted a study where they collected around 23 cases of EC reveal-
ing that this disease [9]:
• Slightly more prevalent in men than women (1,6:1).
• The most common presenting symptoms were abdominal pain followed 
by jaundice.
• Around 69.6% of patients demonstrated peripheral eosinophilia and 30.4% 
had normal eosinophilic count.
One of the challenges that accompanies eosinophilic cholangitis is the fact that it 
can present with a multitude of nonspecific signs and symptoms that makes it hard 
to differentiate from malignancy such as:
• Abdominal mass
• Abdominal pain
• Jaundice
• Generalized fatigue
• Nausea and vomiting
• Weight loss
At this point, it can be anything and a more in-depth investigation is required. 
So where do we go from there?
3.4 Investigations
The issue with eosinophilic cholangitis is that it mimics malignancy very 
closely so what are the options that we have that can help differentiate it from 
cancer?
Normal routine labs, taking into account the presenting symptoms should be 
done.
• CBC with differential to look at the eosinophilic count.
• A liver function test:
 ○ Bilirubin (total and direct) may be elevated.
 ○ ALT and AST may or may not be increased.
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 ○ ALP and GGT are usually increased like any other diseases involving the 
biliary tree.
 ○ Amylase and lipase to rule out a pancreatic cause.
 ○ Since eosinophilic cholangitis can mimic cholangiocarcinoma, tumors 
markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 
19-9 (CA19-9) can be ordered and surprisingly may be elevated making the 
diagnosis even more challenging.
Again, looking at the laboratory investigation, it is still hard to pinpoint the 
diagnosis, the next step would be to move on into imaging modalities.
3.5 Imaging modalities
There are many available imaging modalities that are helpful in visualizing and 
evaluating the biliary system. Noninvasive imaging modalities can demonstrate 
common nonspecific findings of EC such as bile duct wall thickening (segmental 
or diffuse) on US (see Figure 2) and contrast enhanced CT and MRCP with or 
Figure 2. 
This contrast enhanced ultrasound (CEUS) shows thickened wall of intrahepatic bile ducts (from hilar to 
peripheral) with dilation, and the lesion was well enhanced.
Figure 3. 
(a) Computed tomography scan (CT scan) of abdomen and pelvis; (b) magnetic resonance 
cholangiopancreatography (MRCP); (c) endoscopic retrograde cholangiopancreatography showing a focal 
dilation of the biliary tree to the left lobe through the suggestion of subtle ill-defined enhancing mass lesion at 
the level of liver hilum.
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without biliary dilation (see Figure 3). These findings can also be seen in malignant 
processes, hence the need to obtain a brush cytology and tissue biopsy by means of 
performing invasive imaging modalities such as ERCP.
While MRCP is useful in demonstrating an irregular narrowing of the bile duct, 
ERCP and percutaneous transhepatic cholangiography (PTC) provide additional 
information such as irregularities of the common bile duct and the intrahepatic 
ducts as well as the length and site of biliary stricture.
ERCP with brush biopsy, PET-CT (see Figure 4) and an endoscopic guided 
fine needle aspiration (EUS guided FNA) are also used to try to differentiate a 
benign from a malignant cause of biliary tree dilation. As you can see, the CT scan 
shows an ill-defined enhancing mass lesion at the level of liver hilum suggesting 
cholangiocarcinoma.
ERCP with brush biopsy may not show malignant cells.
EUS-guided FNA may show a background of mixed inflammation including 
many eosinophils.
Sometimes the diagnosis can be made, and targeted treatment can be started but 
most of the time, the index of suspicion for malignancy remains high.
3.6 Proposed diagnostic criteria
Matsumoto et al. revealed a characteristic feature of EC that helped rule 
out malignancy: staining of a parenchymal echo in the bile duct wall on 
Figure 4. 
This positron emission tomography-computed tomography (PET-CT) reveals a soft tissue lesion within the 
main left biliary duct but does not show any fluorodeoxyglucose (FDG) activity. This still does not exclude 
cholangiocarcinoma.
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contrast-enhanced ultrasound (CEUS). However, they suggested the following 
requirements to accurately diagnose EC [6]:
1. Thickening of the biliary wall or narrowing of the biliary tree;
2. Eosinophilic infiltration on histopathology;
3. Regression of the stricture or resolution of other biliary abnormalities in the 
absence of treatment or subsequent steroid therapy.
3.7 Treatment
Even though EC is a self-limiting disease, it has a variable course, making precise 
treatment recommendations difficult. The challenge remains to exclude malig-
nancy, which is not always possible with various imaging modalities and biopsies. 
Hence, mandatory surgical intervention is an effective and definitive measure of 
treating EC if there is diagnostic uncertainty.
According to the literature, two cases of EC described a stricture in the common 
hepatic duct that regressed spontaneously without any medical intervention within 
3 weeks, but most of the published cases of EC were treated surgically and received 
a retrograde diagnosis (see Figure 5) [10].
Seow-En et al. suggested that the best option to simultaneously treat a 
stricture, exclude malignancy, and attain a definite diagnosis of EC is surgi-
cal intervention. They also described the advantages of surgery over medical 
therapy, indicating that medical treatment does not eradicate the chance of 
recurrence and that it could put patients at risk of complications of repeated 
steroid therapy [11].
Figure 5. 
(a) Severe degree of periductal onion skin fibrosis (hematoxylin and eosin stain displaying 2× magnification). 
(b and c) The inflammatory infiltrates around the partially damaged bile duct are mostly eosinophilic cells 
(hematoxylin and eosin stain displaying 10× magnification). (d) The eosinophilic count exceeds 40 cells per 
HPF (hematoxylin and eosin stain displaying 40× magnification).
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A diagnostic trial of oral corticosteroid can be tried to see if any resolution 
occurs, however the dose and duration of treatment are yet to be determined due to 
the poor understanding of the diseased natural course.
4. Conclusion
In conclusion, EC is an uncommon, benign, and self-limiting cause of biliary 
stricture. Although this disease has a good response to corticosteroid therapy, it 
often mimics cholangiocarcinoma which makes reaching a definite diagnosis by 
clinical and radiological findings difficult. Hence most cases are treated surgically 
and receive a retrograde diagnosis.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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